In vitro studies in VCP-associated multisystem proteinopathy suggest altered mitochondrial bioenergetics.
Angèle Nalbandian, Katrina J Llewellyn, Arianna Gomez...
https://pubmed.ncbi.nlm.nih.gov/25724235/Actively Recruiting
Led by University of California, Irvine · Updated on 2025-06-18
50
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying families affected by inherited inclusion body myopathy IBM, Paget disease of bone PDB, and frontotemporal dementia FTD, conditions linked to changes in the VCP gene. The goal is to understand how mutations in this gene lead to muscle, bone, and cognitive problems seen in IBMPFD. This observational study involves adults with personal or family histories of these conditions or related muscle and bone disorders. Participants provide biological samples like blood and urine, share family and medical histories, and complete questionnaires about their health. Some participants may be invited to visit the University of California, Irvine, for a two-day program including local procedures such as MRI and bone scans. Travel is only required for those selected for additional testing. Throughout the study, samples are coded to protect participant privacy. The research team collects data to better understand the diseases impact on muscle, bone, and brain function. Participation involves sharing medical information and possibly undergoing imaging tests during the study period, which continues through December 2030.
CONDITIONS
Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
V
Virginia Kimonis, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of California, Irvine
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to December 2030
Participants with a personal or family history of VCP associated disease are observed over time to characterize the condition.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Angèle Nalbandian, Katrina J Llewellyn, Arianna Gomez...
https://pubmed.ncbi.nlm.nih.gov/25724235/Giles D J Watts, M Thorne, M J Kovach...
https://pubmed.ncbi.nlm.nih.gov/12921793/Farzin Farpour, Jamshid Tehranzadeh, Sandra Donkervoort...
https://pubmed.ncbi.nlm.nih.gov/21643886/Sharis Shamirian, Angèle Nalbandian, Manaswitha Khare...
https://pubmed.ncbi.nlm.nih.gov/23715207/Giles D J Watts, Jill Wymer, Margaret J Kovach...
https://pubmed.ncbi.nlm.nih.gov/15034582/Angèle Nalbandian, Svetlana Ghimbovschi, Shlomit Radom-Aizik...
https://pubmed.ncbi.nlm.nih.gov/22686199/Sarju G Mehta, Giles D J Watts, Jennifer L Adamson...
https://pubmed.ncbi.nlm.nih.gov/17224685/Virginia E Kimonis, Sarju G Mehta, Erin C Fulchiero...
https://pubmed.ncbi.nlm.nih.gov/18260132/Hong Joo Kim, Nam Chul Kim, Yong-Dong Wang...
https://pubmed.ncbi.nlm.nih.gov/23455423/Emilie Tresse, Florian A Salomons, Jouni Vesa...
https://pubmed.ncbi.nlm.nih.gov/20104022/University of California, Irvine
Lead Sponsor